H

Hangzhou AGS MedTech Co Ltd
SSE:688581

Watchlist Manager
Hangzhou AGS MedTech Co Ltd
SSE:688581
Watchlist
Price: 60.47 CNY -5.07% Market Closed
Market Cap: 4.9B CNY
Have any thoughts about
Hangzhou AGS MedTech Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Hangzhou AGS MedTech Co Ltd stock under the Base Case scenario is 86.8 CNY. Compared to the current market price of 60.47 CNY, Hangzhou AGS MedTech Co Ltd is Undervalued by 30%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
86.8 CNY
Undervaluation 30%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation Backtest
Hangzhou AGS MedTech Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Hangzhou AGS MedTech Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Hangzhou AGS MedTech Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Hangzhou AGS MedTech Co Ltd

Provide an overview of the primary business activities
of Hangzhou AGS MedTech Co Ltd.

What unique competitive advantages
does Hangzhou AGS MedTech Co Ltd hold over its rivals?

What risks and challenges
does Hangzhou AGS MedTech Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Hangzhou AGS MedTech Co Ltd.

Provide P/S
for Hangzhou AGS MedTech Co Ltd.

Provide P/E
for Hangzhou AGS MedTech Co Ltd.

Provide P/OCF
for Hangzhou AGS MedTech Co Ltd.

Provide P/FCFE
for Hangzhou AGS MedTech Co Ltd.

Provide P/B
for Hangzhou AGS MedTech Co Ltd.

Provide EV/S
for Hangzhou AGS MedTech Co Ltd.

Provide EV/GP
for Hangzhou AGS MedTech Co Ltd.

Provide EV/EBITDA
for Hangzhou AGS MedTech Co Ltd.

Provide EV/EBIT
for Hangzhou AGS MedTech Co Ltd.

Provide EV/OCF
for Hangzhou AGS MedTech Co Ltd.

Provide EV/FCFF
for Hangzhou AGS MedTech Co Ltd.

Provide EV/IC
for Hangzhou AGS MedTech Co Ltd.

Show me price targets
for Hangzhou AGS MedTech Co Ltd made by professional analysts.

What are the Revenue projections
for Hangzhou AGS MedTech Co Ltd?

How accurate were the past Revenue estimates
for Hangzhou AGS MedTech Co Ltd?

What are the Net Income projections
for Hangzhou AGS MedTech Co Ltd?

How accurate were the past Net Income estimates
for Hangzhou AGS MedTech Co Ltd?

What are the EPS projections
for Hangzhou AGS MedTech Co Ltd?

How accurate were the past EPS estimates
for Hangzhou AGS MedTech Co Ltd?

What are the EBIT projections
for Hangzhou AGS MedTech Co Ltd?

How accurate were the past EBIT estimates
for Hangzhou AGS MedTech Co Ltd?

Compare the revenue forecasts
for Hangzhou AGS MedTech Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Hangzhou AGS MedTech Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Hangzhou AGS MedTech Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Hangzhou AGS MedTech Co Ltd compared to its peers.

Compare the P/E ratios
of Hangzhou AGS MedTech Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Hangzhou AGS MedTech Co Ltd with its peers.

Analyze the financial leverage
of Hangzhou AGS MedTech Co Ltd compared to its main competitors.

Show all profitability ratios
for Hangzhou AGS MedTech Co Ltd.

Provide ROE
for Hangzhou AGS MedTech Co Ltd.

Provide ROA
for Hangzhou AGS MedTech Co Ltd.

Provide ROIC
for Hangzhou AGS MedTech Co Ltd.

Provide ROCE
for Hangzhou AGS MedTech Co Ltd.

Provide Gross Margin
for Hangzhou AGS MedTech Co Ltd.

Provide Operating Margin
for Hangzhou AGS MedTech Co Ltd.

Provide Net Margin
for Hangzhou AGS MedTech Co Ltd.

Provide FCF Margin
for Hangzhou AGS MedTech Co Ltd.

Show all solvency ratios
for Hangzhou AGS MedTech Co Ltd.

Provide D/E Ratio
for Hangzhou AGS MedTech Co Ltd.

Provide D/A Ratio
for Hangzhou AGS MedTech Co Ltd.

Provide Interest Coverage Ratio
for Hangzhou AGS MedTech Co Ltd.

Provide Altman Z-Score Ratio
for Hangzhou AGS MedTech Co Ltd.

Provide Quick Ratio
for Hangzhou AGS MedTech Co Ltd.

Provide Current Ratio
for Hangzhou AGS MedTech Co Ltd.

Provide Cash Ratio
for Hangzhou AGS MedTech Co Ltd.

What is the historical Revenue growth
over the last 5 years for Hangzhou AGS MedTech Co Ltd?

What is the historical Net Income growth
over the last 5 years for Hangzhou AGS MedTech Co Ltd?

What is the current Free Cash Flow
of Hangzhou AGS MedTech Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Hangzhou AGS MedTech Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Hangzhou AGS MedTech Co Ltd

Balance Sheet Decomposition
Hangzhou AGS MedTech Co Ltd

Current Assets 2.1B
Cash & Short-Term Investments 2B
Receivables 59.9m
Other Current Assets 56.6m
Non-Current Assets 186.6m
PP&E 164.9m
Intangibles 18.6m
Other Non-Current Assets 3.1m
Current Liabilities 94.2m
Accounts Payable 30.4m
Accrued Liabilities 28.4m
Short-Term Debt 9.4m
Other Current Liabilities 26.1m
Non-Current Liabilities 2.1m
Other Non-Current Liabilities 2.1m
Efficiency

Earnings Waterfall
Hangzhou AGS MedTech Co Ltd

Revenue
426.9m CNY
Cost of Revenue
-122m CNY
Gross Profit
304.8m CNY
Operating Expenses
-111.5m CNY
Operating Income
193.4m CNY
Other Expenses
5.2m CNY
Net Income
198.5m CNY

Free Cash Flow Analysis
Hangzhou AGS MedTech Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Hangzhou AGS MedTech Co Ltd's profitability score is 77/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Free Cash Flow
Positive Gross Profit
Positive Operating Income
77/100
Profitability
Score

Hangzhou AGS MedTech Co Ltd's profitability score is 77/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Hangzhou AGS MedTech Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Hangzhou AGS MedTech Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Hangzhou AGS MedTech Co Ltd

Wall Street analysts forecast Hangzhou AGS MedTech Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hangzhou AGS MedTech Co Ltd is 149.94 CNY with a low forecast of 148.47 CNY and a high forecast of 154.35 CNY.

Lowest
Price Target
148.47 CNY
146% Upside
Average
Price Target
149.94 CNY
148% Upside
Highest
Price Target
154.35 CNY
155% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Hangzhou AGS MedTech Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Hangzhou AGS MedTech Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Hangzhou AGS MedTech Co Ltd

Country

China

Industry

Health Care

Market Cap

4.9B CNY

Dividend Yield

2.4%

Description

Hangzhou AGS MedTech Co., Ltd. engages in the research and development, manufacture, and sale of equipment in minimally invasive diagnosis and treat. The company is headquartered in Hangzhou, Zhejiang and currently employs 501 full-time employees. The company went IPO on 2023-05-19. The firm's main products are used in the field of digestive endoscopy diagnosis and treatment, and are divided into hemostatic closure, EMR/ESD, biopsy, ERCP and diagnosis and treatment instruments according to their therapeutic purposes. The hemostatic closure category includes clip devices and single-use bipolar high-frequency hemostats. Medical instruments include high-frequency surgical equipment, carbon dioxide gas supply devices for endoscopes, and water supply devices for endoscopes. The biopsy category includes single-use biopsy forceps and single-use graspers.

Contact

ZHEJIANG
Hangzhou
Building 5 and Building 6, No. 597 Kangxin Road, Yuhang District
+8657188775216
www.bioags.com

IPO

2023-05-19

Employees

501

Officers

Chairman & GM
Mr. Cheng Zhang

See Also

Discover More
What is the Intrinsic Value of one Hangzhou AGS MedTech Co Ltd stock?

The intrinsic value of one Hangzhou AGS MedTech Co Ltd stock under the Base Case scenario is 86.8 CNY.

Is Hangzhou AGS MedTech Co Ltd stock undervalued or overvalued?

Compared to the current market price of 60.47 CNY, Hangzhou AGS MedTech Co Ltd is Undervalued by 30%.

Back to Top